FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2778168005> ?p ?o ?g. }

• W2778168005 abstract "Abstract Background Clinical testing to determine a suitable dose of linaclotide for Japanese patients with irritable bowel syndrome with constipation ( IBS ‐C) was needed. Methods This was a randomized, double‐blind, placebo‐controlled, dose‐finding trial. Japanese patients with IBS ‐C diagnosed using Rome III criteria (n = 559, men/women: 49/510) were randomly assigned to 1 of 4 linaclotide doses (0.0625, 0.125, 0.25, or 0.5 mg) or placebo for the 12‐week treatment period. The primary endpoint was responder rate of global assessment of relief of IBS symptoms during 12 weeks. The secondary endpoints included responder rates of complete spontaneous bowel movement ( CSBM ), SBM and abdominal pain/discomfort relief and others. Key Results The primary endpoint was 23.2%, 36.2%, 38.7%, 34.8%, and 38.3% in placebo (n = 112), 0.0625 (n = 116), 0.125 (n = 111), 0.25 (n = 112), and 0.5 (n = 107) mg of linaclotide groups with the difference from the placebo group in each linaclotide group (13.0%, 15.5%, 11.6%, 15.1%, P > .05). Monthly responder rate of global assessment of relief of IBS symptoms at month 3 (48.6%), responder rate of CSBM during 12 weeks (45.8%), and responder rate of abdominal pain/discomfort relief during 12 weeks (32.7%) in the 0.5 mg were significantly higher than those in placebo group (29.5%, P < .01; 25.9%, P < .01; and 18.8%, P < .05 respectively). The most frequent adverse event in the linaclotide groups was diarrhea. Conclusions & Inferences This study suggests that a linaclotide dose of 0.5 mg may be appropriate in Japanese patients with IBS ‐C." @default.
• W2778168005 created "2018-01-05" @default.
• W2778168005 creator A5002514925 @default.
• W2778168005 creator A5022159060 @default.
• W2778168005 creator A5023681331 @default.
• W2778168005 creator A5038606327 @default.
• W2778168005 creator A5050118531 @default.
• W2778168005 creator A5058573402 @default.
• W2778168005 creator A5065244190 @default.
• W2778168005 creator A5080798734 @default.
• W2778168005 creator A5089060208 @default.
• W2778168005 date "2017-12-26" @default.
• W2778168005 modified "2023-10-06" @default.
• W2778168005 title "Determining an optimal dose of linaclotide for use in Japanese patients with irritable bowel syndrome with constipation: A phase II randomized, double-blind, placebo-controlled study" @default.
• W2778168005 cites W1532990492 @default.
• W2778168005 cites W1965194352 @default.
• W2778168005 cites W1968228152 @default.
• W2778168005 cites W1969401721 @default.
• W2778168005 cites W1972876743 @default.
• W2778168005 cites W1987172422 @default.
• W2778168005 cites W1995874631 @default.
• W2778168005 cites W1997800332 @default.
• W2778168005 cites W1998904527 @default.
• W2778168005 cites W2008375680 @default.
• W2778168005 cites W2017092019 @default.
• W2778168005 cites W2017242867 @default.
• W2778168005 cites W2024330772 @default.
• W2778168005 cites W2064201279 @default.
• W2778168005 cites W2075061225 @default.
• W2778168005 cites W2080039779 @default.
• W2778168005 cites W2092739781 @default.
• W2778168005 cites W2108727240 @default.
• W2778168005 cites W2115012618 @default.
• W2778168005 cites W2120648209 @default.
• W2778168005 cites W2124063036 @default.
• W2778168005 cites W2126354955 @default.
• W2778168005 cites W2129312389 @default.
• W2778168005 cites W2132145612 @default.
• W2778168005 cites W2166102321 @default.
• W2778168005 cites W2168877909 @default.
• W2778168005 cites W2239183382 @default.
• W2778168005 cites W2267276332 @default.
• W2778168005 cites W2271206729 @default.
• W2778168005 cites W2294867081 @default.
• W2778168005 cites W2318480543 @default.
• W2778168005 cites W2342528407 @default.
• W2778168005 cites W2344024066 @default.
• W2778168005 cites W4211073917 @default.
• W2778168005 doi "https://doi.org/10.1111/nmo.13275" @default.
• W2778168005 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29278278" @default.
• W2778168005 hasPublicationYear "2017" @default.
• W2778168005 type Work @default.
• W2778168005 sameAs 2778168005 @default.
• W2778168005 citedByCount "25" @default.
• W2778168005 countsByYear W27781680052018 @default.
• W2778168005 countsByYear W27781680052019 @default.
• W2778168005 countsByYear W27781680052020 @default.
• W2778168005 countsByYear W27781680052021 @default.
• W2778168005 countsByYear W27781680052022 @default.
• W2778168005 countsByYear W27781680052023 @default.
• W2778168005 crossrefType "journal-article" @default.
• W2778168005 hasAuthorship W2778168005A5002514925 @default.
• W2778168005 hasAuthorship W2778168005A5022159060 @default.
• W2778168005 hasAuthorship W2778168005A5023681331 @default.
• W2778168005 hasAuthorship W2778168005A5038606327 @default.
• W2778168005 hasAuthorship W2778168005A5050118531 @default.
• W2778168005 hasAuthorship W2778168005A5058573402 @default.
• W2778168005 hasAuthorship W2778168005A5065244190 @default.
• W2778168005 hasAuthorship W2778168005A5080798734 @default.
• W2778168005 hasAuthorship W2778168005A5089060208 @default.
• W2778168005 hasBestOaLocation W27781680051 @default.
• W2778168005 hasConcept C108797546 @default.
• W2778168005 hasConcept C126322002 @default.
• W2778168005 hasConcept C142724271 @default.
• W2778168005 hasConcept C168563851 @default.
• W2778168005 hasConcept C197934379 @default.
• W2778168005 hasConcept C203092338 @default.
• W2778168005 hasConcept C204787440 @default.
• W2778168005 hasConcept C27081682 @default.
• W2778168005 hasConcept C2778271842 @default.
• W2778168005 hasConcept C2780955771 @default.
• W2778168005 hasConcept C2781112942 @default.
• W2778168005 hasConcept C71924100 @default.
• W2778168005 hasConcept C90924648 @default.
• W2778168005 hasConceptScore W2778168005C108797546 @default.
• W2778168005 hasConceptScore W2778168005C126322002 @default.
• W2778168005 hasConceptScore W2778168005C142724271 @default.
• W2778168005 hasConceptScore W2778168005C168563851 @default.
• W2778168005 hasConceptScore W2778168005C197934379 @default.
• W2778168005 hasConceptScore W2778168005C203092338 @default.
• W2778168005 hasConceptScore W2778168005C204787440 @default.
• W2778168005 hasConceptScore W2778168005C27081682 @default.
• W2778168005 hasConceptScore W2778168005C2778271842 @default.
• W2778168005 hasConceptScore W2778168005C2780955771 @default.
• W2778168005 hasConceptScore W2778168005C2781112942 @default.
• W2778168005 hasConceptScore W2778168005C71924100 @default.
• W2778168005 hasConceptScore W2778168005C90924648 @default.
• W2778168005 hasFunder F4320323024 @default.
• W2778168005 hasIssue "5" @default.
• W2778168005 hasLocation W27781680051 @default.

• next